Zhendong Pharmacy(SZ:300158) Sou Hu Cai Jing·2025-11-16 18:15Core Viewpoint - The company, Zhendong Pharmaceutical, is focusing on enhancing its operational performance and product competitiveness to improve long-term shareholder value, despite facing challenges in stock price compared to peers [2]. Group 1: Stock Performance - As of November 14, 2025, Zhendong Pharmaceutical's stock closed at 7.37 yuan, reflecting a 3.08% increase with a turnover rate of 7.92% and a trading volume of 795,400 shares, amounting to a transaction value of 587 million yuan [1]. - On the same day, there was a net outflow of 17.61 million yuan from major funds, indicating continued withdrawal of institutional investment [2]. Group 2: Company Strategy - The company is committed to optimizing its product matrix, strengthening the competitiveness of its product pipeline, and enhancing channel development to boost performance [2]. - The company has completed its share repurchase plan, which is part of its strategy to return value to shareholders [2].